Dalotuzumab (Anti-IGF1R / CD221)
Dalotuzumab (Anti-IGF1R / CD221) (A2815-GRP)
Products
Description
Dalotuzumab (Anti-IGF1R / CD221) is a recombinant humanized monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF1R) with potential antineoplastic activity. MW : 146.78 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2815 |
| Target | CD markers |